Number of vaccines administered at Semmelweis University - 18. May 2022
530637 Total vaccines

Responding to the rapidly changing domestic and international environment, Semmelweis University has established a number of university-owned companies in recent years. With the help of these companies, the University now offers a variety of business services and aims to strengthen its position as an attractive partner for those seeking investment and cooperation opportunities in Hungary.

Semmelweis Medical Services Ltd.

Wholly owned by the University, Semmelweis Health Care Service Ltd. (SEK) offers high quality private health care services using Semmelweis University’s clinical background and the expertise and professional experience of its clinical physicians. Its services are sought out by Hungarian and international patients alike, for a variety of reasons, including long waiting lists, the particular service not being covered by the National Health Service Fund (OEP), or simply because they wish to receive superior care.

The services are provided by the University’s current and former specialist doctors at the University’s various clinical departments in offices specially designed for the purpose.

Managing director: Róbert Kovács
Tel.: +36 20 663 2666

Semmelweis Publishing and Multimedia Studio Ltd.

Semmelweis University has a 100% ownership over Semmelweis Publishing and Multimedia Studios Ltd. Its express intent is to serve Hungarian medical, pharmaceutical, and natural science with due humility and in a way that is worthy of the University’s national and international reputation, while taking a decidedly new and modern approach.

It strives to be a professional and quality member of the Hungarian specialised publishing industry while maintaining the medical, pharmaceutical and natural science publishing traditions. This is made possible by our experienced and committed staff, working under the direction of an excellent management team.

Website: (in Hungarian only)
Managing director: dr. László Táncos
Address: 1089 Budapest, Nagyvárad tér 4.
Tel.: (+36 ) 210-4403
Fax: (+36 1) 210-1904

Bionic Innovation Centre Ltd.

The Government of Hungary adopted the National Bionics Program implemented by the NKFI Fund by Resolution 1336/2017 (VI.9.). The consortium member BIK Nkft. is the company of the 250-year-old Semmelweis University and Pázmány Péter Catholic University, with an equal share of partnership of. It performs industrial protection and commercial adaptation of the results of bionic research projects.

Managing director: Dr. Tamás Kantár PhD
Address: 1088 Budapest, Szentkirályi utca 46.

SMS – Semmelweis Medical Studies Ltd.

Semmelweis University has a 100% ownership over SMS Ltd, which aims to manage and organise the seamless enrollment of foreign students at Semmelweis University.

With the help of its  international network of international the company promotes the university’s foreign language programmes and organises both the application and enrollment procedures.

Website: and  
Managing director: Dr. István Gera
Mailing address: 1085 Budapest, Üllői út 26.
Telephone: +36 30 312 46 63


The European Commission’s Research Executive Agency, the National Research, Development and Innovation Office, the Hungarian Academy of Sciences, the Hungarian Academy of Sciences Biological Research Centre in Szeged, the University of Szeged, the University of Debrecen, Semmelweis University and the European Molecular Biology Laboratory (“EMBL”) signed a multilateral agreement within the framework of Horizon 2020 programme. The agreement promotes institutions’ cooperation in the realisation of research and development projects, the identification and achievement of goals, including the foundation of the HCEMM Molecular Medicine Excellence Centre.

HCEMM Ltd. was founded by Semmelweis University, the University of Szeged, and the Hungarian Academy of Sciences Biological Research Centre in Szeged.

HCEMM Ltd. (HCEMM) is a new excellence centre with headquarters in Szeged, which will provide research- and educational services in the field of molecular medicine.

Managing director: Dr. Christoph W. Sensen
Address: 6720 Szeged, Dugonics tér 13.
Telephone: +36 30 127 0121